IT1223150B - Compressa per uso oftalmico e rilascio controllato della sostanza attiva - Google Patents
Compressa per uso oftalmico e rilascio controllato della sostanza attivaInfo
- Publication number
- IT1223150B IT1223150B IT22682/87A IT2268287A IT1223150B IT 1223150 B IT1223150 B IT 1223150B IT 22682/87 A IT22682/87 A IT 22682/87A IT 2268287 A IT2268287 A IT 2268287A IT 1223150 B IT1223150 B IT 1223150B
- Authority
- IT
- Italy
- Prior art keywords
- tablet
- active substance
- controlled release
- ophthalmic use
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22682/87A IT1223150B (it) | 1987-11-18 | 1987-11-18 | Compressa per uso oftalmico e rilascio controllato della sostanza attiva |
| EP88118928A EP0316838A1 (en) | 1987-11-18 | 1988-11-14 | Tablet for opthalmic use with controlled release of the active substance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22682/87A IT1223150B (it) | 1987-11-18 | 1987-11-18 | Compressa per uso oftalmico e rilascio controllato della sostanza attiva |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8722682A0 IT8722682A0 (it) | 1987-11-18 |
| IT1223150B true IT1223150B (it) | 1990-09-12 |
Family
ID=11199217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT22682/87A IT1223150B (it) | 1987-11-18 | 1987-11-18 | Compressa per uso oftalmico e rilascio controllato della sostanza attiva |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0316838A1 (it) |
| IT (1) | IT1223150B (it) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4900552A (en) * | 1988-03-30 | 1990-02-13 | Watson Laboratories, Inc. | Mucoadhesive buccal dosage forms |
| US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| IL100112A (en) * | 1991-11-21 | 1996-01-31 | Yeda Res & Dev | Microdelivery device for enhanced drug administration to the eye |
| FR2688694B1 (fr) * | 1992-03-20 | 1999-06-25 | Vetoquinol Sa | Insert ophtalmique bioadhesif. |
| US5178635A (en) * | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
| US5773021A (en) * | 1994-03-14 | 1998-06-30 | Vetoquinol S.A. | Bioadhesive ophthalmic insert |
| FR2737661B1 (fr) * | 1995-08-08 | 1997-10-31 | Mgi Pharma Inc | Composition pharmaceutique sous forme de comprimes comprenant du chlorhydrate de pilocarpine |
| US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| US6217895B1 (en) | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| FR2833493B1 (fr) * | 2001-12-18 | 2005-09-23 | Ioltechnologie Production | Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3811444A (en) * | 1972-12-27 | 1974-05-21 | Alza Corp | Bioerodible ocular device |
| DE3068986D1 (en) * | 1980-01-28 | 1984-09-27 | Merck & Co Inc | Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors |
| PT75625B (en) * | 1981-10-08 | 1985-12-09 | Merck & Co Inc | Process for preparing biosoluble ocular insert |
| CH653550A5 (de) * | 1981-10-20 | 1986-01-15 | Sandoz Ag | Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich. |
| ATE151286T1 (de) * | 1983-11-14 | 1997-04-15 | Columbia Lab Inc | Bioadhäsive mittel |
| IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
-
1987
- 1987-11-18 IT IT22682/87A patent/IT1223150B/it active
-
1988
- 1988-11-14 EP EP88118928A patent/EP0316838A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0316838A1 (en) | 1989-05-24 |
| IT8722682A0 (it) | 1987-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8719064A0 (it) | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive. | |
| DE3880593D1 (de) | Arzneizubereitungen mit retardierter wirkstofffreisetzung. | |
| NO884154L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
| KR910700249A (ko) | 신규 치료학적 활성 화합물 및 그의 제조 방법 | |
| NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO884473L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler. | |
| NO171269C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter | |
| IT8722682A0 (it) | Compressa per uso oftalmico e rilascio controllato della sostanza attiva. | |
| DK397388D0 (da) | Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater | |
| NO900919D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske etere. | |
| NO900697D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| BR8802557A (pt) | Agente fisiologicamente ativo para uso agricola | |
| NO921603D0 (no) | Fremgangsmaate til fremstilling av et aktivt findelt agregat for bruk til betong | |
| GB2181053B (en) | Pharmaceutical formulations with controlled release of the active substance | |
| NO170086C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener | |
| NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO922437D0 (no) | Terapeutisk aktive fluorsubstituerte benzimidazoler, fremgangsmaate for deres fremstilling samt deres anvendelse | |
| GR862457B (en) | Pharmaceutical formulations with controlled release of the active substance | |
| NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19941129 |